Your browser doesn't support javascript.
loading
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes.
Leslie, Richard David; Ma, Ronald Ching Wan; Franks, Paul W; Nadeau, Kristen J; Pearson, Ewan R; Redondo, Maria Jose.
Affiliation
  • Leslie RD; Blizard Institute, Barts and Royal London Medical School, London, UK. Electronic address: r.d.g.leslie@qmul.ac.uk.
  • Ma RCW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China; Chinese University of Hong Kong-Shanghai Jiao Tong University Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong Institute of Diabetes and Obesity,
  • Franks PW; Novo Nordisk Foundation, Hellerup, Denmark; Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Malmo, Sweden; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Harvard T H Chan School of Publi
  • Nadeau KJ; Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
  • Pearson ER; Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.
  • Redondo MJ; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Lancet Diabetes Endocrinol ; 11(11): 848-860, 2023 11.
Article in En | MEDLINE | ID: mdl-37804855
ABSTRACT
Diabetes is a highly heterogeneous condition; yet, it is diagnosed by measuring a single blood-borne metabolite, glucose, irrespective of aetiology. Although pragmatically helpful, disease classification can become complex and limit advances in research and medical care. Here, we describe diabetes heterogeneity, highlighting recent approaches that could facilitate management by integrating three disease models across all forms of diabetes, namely, the palette model, the threshold model and the gradient model. Once diabetes has developed, further worsening of established diabetes and the subsequent emergence of diabetes complications are kept in check by multiple processes designed to prevent or circumvent metabolic dysfunction. The impact of any given disease risk factor will vary from person-to-person depending on their background, diabetes-related propensity, and environmental exposures. Defining the consequent heterogeneity within diabetes through precision medicine, both in terms of diabetes risk and risk of complications, could improve health outcomes today and shine a light on avenues for novel therapy in the future.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Complications / Diabetes Mellitus, Type 2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Complications / Diabetes Mellitus, Type 2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2023 Document type: Article